Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines01:30

Cancer Vaccines

917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence01:22

Development of Immunocompetence

759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity01:07

Teratogenicity

3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression.

Nature communications·2026
Same author

Guidelines for T cell nomenclature.

Nature reviews. Immunology·2025
Same author

Sweating the Small Stuff: A Closer Look at the Endocrine Pancreas Throughout Stages of Type 1 Diabetes Progression.

Diabetes·2025
Same author

Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.

The Journal of clinical endocrinology and metabolism·2025
Same author

Integrated histopathology of the human pancreas throughout stages of type 1 diabetes progression.

Research square·2025
Same author

Prolonged but finite antigen presentation promotes reversible defects of "helpless" memory CD8<sup>+</sup> T cells.

Immunity·2025

Related Experiment Video

Updated: Jan 6, 2026

Mitral Valve Prolapse III: Nursing Management
01:19

Mitral Valve Prolapse III: Nursing Management

Published on: June 19, 2025

252

An immunologic homunculus for type 1 diabetes.

Dirk Homann1, George S Eisenbarth

  • 1Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado, USA.

The Journal of Clinical Investigation
|May 4, 2006
PubMed
Summary

Transforming growth factor-beta (TGF-β) signaling in T cells recognizing the insulin peptide B:9-23 is crucial for preventing autoimmune diabetes in NOD mice. This protective mechanism involves both paracrine and autocrine TGF-β actions.

More Related Videos

Cancer Vaccines
01:30

Cancer Vaccines

917
Development of Immunocompetence
01:22

Development of Immunocompetence

759

Related Experiment Videos

Last Updated: Jan 6, 2026

Mitral Valve Prolapse III: Nursing Management
01:19

Mitral Valve Prolapse III: Nursing Management

Published on: June 19, 2025

252
Cancer Vaccines
01:30

Cancer Vaccines

917
Development of Immunocompetence
01:22

Development of Immunocompetence

759

Area of Science:

  • Immunology
  • Autoimmunity
  • T cell biology

Background:

  • Autoimmune diseases, like type 1 diabetes in non-obese diabetic (NOD) mice, arise from immune recognition of self-antigens.
  • T cell responses to autoantigens can be either pathogenic (leading to disease) or protective (preventing disease).

Discussion:

  • The study by Du et al. reveals that T cells recognizing the insulin peptide B:9-23 utilize transforming growth factor-beta (TGF-β) signaling for protection against diabetes.
  • This TGF-β signaling operates through both paracrine (acting on nearby cells) and autocrine (acting on the same cell) mechanisms.
  • The insulin peptide B:9-23 and a conserved T cell receptor (TCR) motif may form an 'immunologic homunculus,' explaining why T cells frequently target insulin.

Key Insights:

  • TGF-β signaling mediated by T cells recognizing insulin peptide B:9-23 is essential for protection against autoimmune diabetes in NOD mice.
  • Both paracrine and autocrine actions of TGF-β contribute to this protective T cell response.
  • A conserved 'immunologic homunculus' involving insulin peptide B:9-23 and TCR motifs may underlie the dual T cell response outcomes (protective vs. pathogenic).

Outlook:

  • Further research into the 'immunologic homunculus' could identify novel therapeutic targets for autoimmune diabetes.
  • Understanding the precise mechanisms of TGF-β's dual role in T cell responses may lead to strategies for modulating autoimmunity.